Применение лекарственных средств группы метаболиков для лечения экспериментальных геморрагических лихорадок, вызываемых вирусами Марбург и Эбола

The protective properties of the two drugs (medicines) of the group of metabolites on 2-4 day albino mice-suckers, infected with Ebola and Marburg viruses that cause severe hemorrhagic fevers with a high percentage of mortality, are evaluated. High protective properties of the both drugs applied for treatment of experimental infections are revealed. Drugs are recommended for use as a means of providing emergency medical care to patients in hemorrhagic fever Marburg and Ebola in addition to the pathogenetic therapy.